Skip to content
Health

Blood Pressure Medication Recalled Nationwide Over Metal Contamination Risk

Breckenridge Pharmaceutical has issued a voluntary recall for one lot of propranolol hydrochloride extended-release capsules due to potential metal fragments.

By 2 min read

Breckenridge Pharmaceutical, Inc. issued a voluntary nationwide recall for a single lot of blood pressure medication after discovering that the pills could be contaminated with metal. The recall affects 60mg propranolol hydrochloride extended-release capsules, which were manufactured by Philadelphia-based Adare Pharma Solutions and distributed to wholesalers and pharmacies across the United States between October 26 and November 4.

The affected medication is packaged in 100-count bottles under National Drug Code 51991-817-01, with lot number PK25110035 and an expiration date of May 2029. According to the company's press release, the recalled lot shares intermediate material suspected to be the source of metal contamination that was previously identified in a separate, unreleased lot.

Health officials warn that consuming products from the impacted batch carries significant safety risks. "Use of product from the affected lot could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine," the company stated in its official announcement.

As of this week, Breckenridge Pharmaceutical confirmed that it has not received any reports of injuries or adverse health events connected to the recall. Patients currently taking the medication are advised to stop immediately and consult their healthcare providers for medical advice and instructions on obtaining a replacement.

Consumers can return any unused portions of the pills to the pharmacy where they originally purchased them. Meanwhile, wholesalers, pharmacies, and other retail entities have been directed to inspect their inventories, quarantine any impacted stock, and halt all distribution immediately.

For individuals with questions or those seeking assistance regarding the recall, Breckenridge Pharmaceutical's service provider, Qualanex, can be reached by phone or email. Customers and healthcare providers are also encouraged to report any adverse reactions or quality issues to the United States Food and Drug Administration's MedWatch program.

Propranolol capsules are widely prescribed to manage high blood pressure, as well as to treat other medical conditions such as chest pain, migraines, and tremors. This safety action follows several other recent pharmaceutical recalls in the United States, including a late October recall of metoprolol tartrate tablets by Advagen Pharma Limited due to foreign tablet mix-ups, and a distinct dissolution failure recall by Macleods Pharmaceuticals.

Sources

Related stories